Journal of Orthopedic Oncology
Open Access

Enchondroma; Bone tumor; Diagnosis; Prognosis; Radiography; Magnetic Resonance imaging; Chondrosarcoma; Surgical intervention; Benign tumor

Introduction

Enchondromas are benign bone tumors originating from cartilage cells. While typically asymptomatic and often incidentally discovered, they can pose diagnostic and management challenges in certain cases. Understanding the clinical features, diagnostic modalities, management strategies, and prognosis associated with enchondromas is crucial for clinicians to provide optimal care to affected individuals [1]. Enchondromas, benign bone tumors originating from cartilage cells, are a common finding in clinical practice, particularly affecting the bones of the hands and feet. Despite being predominantly asymptomatic, they can present with pain, swelling, or pathologic fractures, posing diagnostic challenges and necessitating appropriate management strategies. Understanding the clinical insights into enchondroma, including its diagnosis, management, and prognosis, is essential for clinicians to provide optimal care to affected individuals [2].

The diagnosis of enchondroma typically involves a combination of clinical evaluation and imaging studies. Radiographs often reveal characteristic lytic lesions with stippled calcifications, while magnetic resonance imaging (MRI) provides detailed anatomical information, aiding in lesion characterization. However, definitive diagnosis may require histopathological examination via biopsy, especially in cases where malignancy is suspected [3].

Management approaches for enchondromas vary depending on factors such as lesion size, location, symptoms, and risk of malignant transformation. While asymptomatic lesions may be managed conservatively with periodic observation, symptomatic or high-risk lesions may require surgical intervention. Prognosis for most enchondromas is favorable, although vigilance is necessary for early detection of malignant transformation into chondrosarcoma [4].

Clinical presentation

Enchondromas commonly affect the bones of the hands and feet, particularly the phalanges and metacarpals/metatarsals. They may present as painless masses or be discovered incidentally on imaging studies performed for unrelated reasons. In some cases, patients may experience pain, swelling, or pathologic fractures, especially if the tumor undergoes malignant transformation into chondrosarcoma.

Diagnostic workup

The diagnosis of enchondroma begins with a thorough clinical evaluation and imaging studies. Radiographs typically reveal well-defined lytic lesions with stippled calcifications, often described as “popcorn-like” or “rings-and-arcs” appearance. Magnetic resonance imaging (MRI) can provide detailed anatomical information and aid in distinguishing enchondromas from other bone lesions. If malignancy is suspected, biopsy may be warranted for histopathological examination [5].

Management approaches

The management of enchondromas depends on various factors, including the size, location, symptoms, and risk of malignant transformation. Asymptomatic lesions with characteristic radiographic features may simply require periodic observation with serial imaging to monitor for any changes. Symptomatic lesions or those at risk of pathological fractures may necessitate surgical intervention, which can range from curettage and bone grafting to more extensive procedures like resection and reconstruction. In cases of malignant transformation, wide resection followed by adjuvant therapy may be indicated [6].

Prognosis

Most enchondromas have an excellent prognosis, with the majority remaining indolent and not requiring intervention. However, the risk of malignant transformation into chondrosarcoma exists, albeit relatively low. Factors associated with an increased risk of malignancy include rapid growth, large size, cortical erosion, and presence of soft tissue mass. Regular follow-up with clinical examination and imaging studies is essential to detect any signs of malignant transformation early, enabling timely intervention and improving outcomes [7].

Discussion

Enchondromas are benign bone tumors that originate from cartilage cells, commonly found in the bones of the hands and feet. While often asymptomatic, they can present with pain, swelling, or pathologic fractures, necessitating clinical evaluation and appropriate management strategies. This discussion explores the diagnostic, management, and prognostic aspects of enchondromas.

Diagnosis

The diagnosis of enchondroma begins with a thorough clinical assessment and imaging studies. Radiographs typically reveal well-defined lytic lesions with stippled calcifications, often demonstrating a characteristic "popcorn-like" or "rings-and-arcs" appearance. However, radiographic findings alone may not always be conclusive, necessitating further imaging modalities such as magnetic resonance imaging (MRI). MRI provides detailed anatomical information, allowing for better characterization of the lesion and assessment of its relationship with surrounding structures. In cases where malignancy is suspected, biopsy may be warranted for histopathological examination, which remains the gold standard for definitive diagnosis [8].

Management

The management of enchondromas is guided by various factors, including the size, location, symptoms, and risk of malignant transformation. Asymptomatic lesions with characteristic radiographic features may be managed conservatively with periodic observation and serial imaging to monitor for any changes. However, symptomatic lesions or those at risk of pathological fractures may require intervention. Surgical options include curettage and bone grafting, which involve the removal of the tumor and filling the defect with bone graft material to promote healing. In cases where the lesion is large or associated with significant morbidity, more extensive surgical procedures such as resection and reconstruction may be necessary. The choice of surgical approach depends on the individual patient's clinical presentation and the extent of the disease [9].

Prognosis

Overall, the prognosis for patients with enchondroma is favorable, with the majority of lesions remaining indolent and not requiring intervention. However, there is a risk of malignant transformation into chondrosarcoma, although this occurs relatively infrequently. Factors associated with an increased risk of malignancy include rapid growth, large size, cortical erosion, and the presence of a soft tissue mass. Therefore, regular follow-up with clinical examination and imaging studies is essential to detect any signs of malignant transformation early, enabling timely intervention and improving outcomes [10].

Conclusion

Enchondromas are common benign bone tumors that can pose diagnostic and management challenges in certain cases. While typically asymptomatic, they can cause symptoms and complications, necessitating appropriate clinical evaluation and management strategies. Radiographic and MRI imaging modalities play a crucial role in diagnosis, while management approaches range from observation to surgical intervention, depending on various factors. Despite the generally favorable prognosis, vigilance is required for early detection of malignant transformation into chondrosarcoma. A multidisciplinary approach involving orthopedic surgeons, radiologists, and pathologists is essential to optimize patient care and outcomes in individuals with enchondroma.

Conflict of Interest

None

Acknowledgement

None

1. Wang CC, Schulz MD (1953) Ewing’s sarcoma; a study of fifty cases treated at the Massachusetts General Hospital, 1930-1952 inclusive. N Engl J Med 248:571-576.

Indexed at, Google Scholar, Crossref

2. Anderton J, Moroz V, Marec-Berard P, Gaspar N, Laurence V, et al. (2020) International randomised controlled trial for the treatment of newly diagnosed Ewing sarcoma family of tumours. Trials 21:96.

Indexed at, Google Scholar, Crossref

3. Haeusler J, Ranft A, Boelling T, Gosheger G, Braun-Munzinger G, et al. (2010) The value of local treatment in patients with primary, disseminated, multifocal Ewing sarcoma (PDMES). Cancer 116:443-450.

Indexed at, Google Scholar, Crossref

4. Barker LM, Pendergrass TW, Sanders JE, Hawkins DS. (2005) Survival after recurrence of Ewing’s sarcoma family of tumors. J Clin Oncol 23:4354-4362.

Indexed at, Google Scholar, Crossref

5. Anderson WJ, Doyle LA (2021) Updates from the 2020 World Health Organization Classification of Soft Tissue and Bone Tumours. Histopathology 78: 644-657.

Indexed at, Google Scholar, Crossref

6. Exner GU, Kurrer MO, Mamisch-Saupe N, Cannon SR (2017) The tactics and technique of musculoskeletal biopsy. EFORT Open Rev 2:51-57.

Indexed at, Google Scholar, Crossref

7. Khoo MM, Saifuddin A (2013) The role of MRI in image-guided needle biopsy of focal bone and soft tissue neoplasms. Skeletal Radiol 42:905-915.

Indexed at, Google Scholar, Crossref

8. Singh HK, Kilpatrick SE, Silverman JF (2004) Fine needle aspiration biopsy of soft tissue sarcomas: Utility and diagnostic challenges. Adv Anat Pathol 11:24-37.

Indexed at, Google Scholar, Crossref

9. Gerrand C, Bate J, Seddon B, Dirksen U, Randall RL, et al. (2020) Seeking international consensus on approaches to primary tumour treatment in Ewing sarcoma. Clin Sarcoma Res 10:21.

Indexed at, Google Scholar, Crossref

10. Grohs JG, Zoubek A, Jugovic D, Kovar H, Windhager R (2004) Intraoperative dissemination of tumour cells in patients with Ewing tumours detected by RT-PCR. Int Orthop 28:222-225.

Indexed at, Google Scholar, Crossref